Prediabetic nephropathy as an early consequence of the high-calorie/high- fat diet: Relation to oxidative stress

Endocrinology

Volumn 153, Issue 3, 2012, Pages 1152-1161

  Shevalye, Hanna ^a   Lupachyk, Sergey ^a   Watcho, Pierre ^a   Stavniichuk, Roman ^a   Khazim, Khaled ^b   Abboud, Hanna E ^b   Obrosova, Irina G ^a  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 HYDROXYICOSATETRAENOIC ACID; 4 HYDROXYNONENAL; 8 ISOPROSTANE; ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; EUKARYOTIC INITIATION FACTOR ALPHA; GLUCOSE; INITIATION FACTOR; NEPHRIN; PHOSPHOEUKARYOTIC INITIATION FACTOR ALPHA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIRTUIN 1; SORBITOL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; DIABETIC NEPHROPATHY; ENZYMATIC ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GLUCOSE BLOOD LEVEL; HYPERINSULINEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IMPAIRED GLUCOSE TOLERANCE; KIDNEY INJURY; KIDNEY MASS; KIDNEY MEDULLA; LIPID DIET; MALE; MOUSE; NONHUMAN; OBESITY; OXIDATIVE STRESS; PODOCYTE; POLYURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINE VOLUME; WESTERN BLOTTING;

ANIMAL FEED; ANIMALS; ARACHIDONATE 12-LIPOXYGENASE; ARACHIDONATE 15-LIPOXYGENASE; DIABETIC NEPHROPATHIES; DIET; DIET, HIGH-FAT; KIDNEY CORTEX; MALE; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; OBESITY; OXIDATIVE STRESS; PODOCYTES; PREDIABETIC STATE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84857418008     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1997     Document Type: Article

References (59)

1. Yach D, Stuckler D, Brownell KD 2006 Epidemiologic and economic consequences of the global epidemics of obesity and diabetes. Nat Med 12:62-66 (Pubitemid 43050076)
2. Reindel J, Zander E, Heinke P, Kohnert KD, Allwardt C, Kerner W 2004 The metabolic syndrome in patients with type 1 diabetes mellitus. Associations with cardiovascular risk factors and cardiovascular morbidity. Herz 29:463-469 (Pubitemid 39166102)
3. Sumner CJ, Sheth S, Griffin JW, Cornblath DR, Polydefkis M 2003 The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60:108-111 (Pubitemid 36070653)
4. Laitinen T, Lindström J, Eriksson J, Ilanne-Parikka P, Aunola S, Keinänen-Kiukaanniemi S, Tuomilehto J, Uusitupa M 2011 Cardiovascular autonomic dysfunction is associated with central obesity in persons with impaired glucose tolerance. Diabet Med 28:699-704
5. Plantinga LC, Crews DC, Coresh J, Miller 3rd ER, Saran R, Yee J, Hedgeman E, Pavkov M, Eberhardt MS, Williams DE, Powe NR, Centers for Disease Control and Prevention CKD Surveillance Team 2010 Prevalence of chronic kidney disease in U.S. adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 5:673-682
6. Hanna-Moussa A, Gardner MJ, Kurukulasuriya LR, Sowers JR 2009 Dysglycemia/prediabetes and cardiovascular risk factors. Rev Cardiovasc Med 10:202-208
7. Bray GA, Lovejoy JC, Smith SR, DeLany JP, Lefevre M, Hwang D, Ryan DH, York DA 2002 The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J Nutr 132:2488-2491 (Pubitemid 35013224)
8. Ohtsubo K, Takamatsu S, Minowa MT, Yoshida A, Takeuchi M, Marth JD 2005 Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123:1307-1321 (Pubitemid 41821787)
9. Obrosova IG, Ilnytska O, Lyzogubov VV, Pavlov IA, Mashtalir N, Nadler JL, Drel VR 2007 High-fat diet induced neuropathy of prediabetes and obesity: effects of "healthy" diet and aldose reductase inhibition. Diabetes 56:2598-2608 (Pubitemid 47523268)
10. Jakulj F, Zernicke K, Bacon SL, van Wielingen LE, Key BL, West SG, Campbell TS 2007 A high-fat meal increases cardiovascular reactivity to psychological stress in healthy young adults. J Nutr 137:935-939 (Pubitemid 46596890)
11. Kobayasi R, Akamine EH, Davel AP, Rodrigues MA, Carvalho CR, Rossoni LV 2010 Oxidative stress and inflammatory mediators contribute to endothelial dysfunction in high-fat diet-induced obesity in mice. J Hypertens 28:2111-2119
12. Toque HA, da Silva FH, Calixto MC, Lintomen L, Schenka AA, Saad MJ, Zanesco A, Antunes E 2011 High-fat diet associated with obesity induces impairment of mouse corpus cavernosum responses. BJU Int 107:1628-1634
13. Seitz O, Schürmann C, Hermes N, Müller E, Pfeilschifter J, Frank S, Goren I 2010 Wound healing in mice with high-fat diet- or ob geneinduced diabetes-obesity syndromes: a comparative study. Exp Diabetes Res 2010:476969
14. Wei P, Lane PH, Lane JT, Padanilam BJ, Sansom SC 2004 Glomerular structural and functional changes in a high-fat diet mouse model of early-stage type 2 diabetes. Diabetologia 47:1541-1549
15. Wei P, Grimm PR, Settles DC, Balwanz CR, Padanilam BJ, Sansom SC 2009 Simvastatin reverses podocyte injury but not mesangial expansion in early stage type 2 diabetes mellitus. Ren Fail 31:503-513
16. Harcourt BE, Sourris KC, Coughlan MT, Walker KZ, Dougherty SL, Andrikopoulos S, Morley AL, Thallas-Bonke V, Chand V, Penfold SA, de Courten MP, Thomas MC, Kingwell BA, Bierhaus A, Cooper ME, Courten B, Forbes JM 2011 Targeted reduction of advanced glycation improves renal function in obesity. Kidney Int 80:190-198
17. Ruggiero C, Ehrenshaft M, Cleland E, Stadler K 2011 High fat diet induces an initial adaptation of mitochondrial bioenergetics in the kidney despite evident oxidative stress and mitochondrial ROS production. Am J Physiol Endocrinol Metab 300:E1047-E1058
18. Marshall SM, Flyvbjerg A 2006 Prevention and early detection of vascular complications of diabetes. BMJ 333:475-480 (Pubitemid 44343444)
19. He W, Wang Y, Zhang MZ, You L, Davis LS, Fan H, Yang HC, Fogo AB, Zent R, Harris RC, Breyer MD, Hao CM 2010 Sirt1 activation protects the mouse renal medulla from oxidative injury. J Clin Invest 120:1056-1068
20. Shevalye H, Maksimchyk Y, Watcho P, Obrosova IG 2010 Poly- (ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease. Biochim Biophys Acta 1802:1020-1027
21. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE 2005 Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280:39616-39626 (Pubitemid 41713921)
22. Rangan GK, Tesch GH 2007 Quantification of renal pathology by image analysis. Nephrology 12:553-558
23. Figarola JL, Loera S, Weng Y, Shanmugam N, Natarajan R, Rahbar S 2008 LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat. Diabetologia 51:882-891
24. Obrosova IG, Van Huysen C, Fathallah L, Cao X, Stevens MJ, Greene DA 2000 Evaluation of α(1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense. FASEB J 14:1548-1558 (Pubitemid 30636559)
25. Glassock RJ 2010 Is the presence of microalbuminuria a relevant marker of kidney disease? Curr Hypertens Rep 12:364-368
26. Radbill B, Murphy B, LeRoith D 2008 Rationale and strategies for early detection and management of diabetic kidney disease. Mayo Clin Proc 83:1373-1381
27. Klausen KP, Parving HH, Scharling H, Jensen JS 2007 The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality. J Intern Med 262:470-478 (Pubitemid 47404367)
28. Klausen KP, Parving HH, Scharling H, Jensen JS 2009 Microalbuminuria and obesity: impact on cardiovascular disease and mortality. Clin Endocrinol (Oxf) 71:40-45
29. Andersen S, Mischak H, Zürbig P, Parving HH, Rossing P 2010 Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria. BMC Nephrol 11:29
30. Oates PJ 2010 Aldose reductase inhibitors and diabetic kidney disease. Curr Opin Investig Drugs 11:402-417
31. Liu H, Luo Y, Zhang T, Zhang Y, Wu Q, Yuan L, Chung SS, Oates PJ, Yang JY 2011 Genetic deficiency of aldose reductase counteractsthe development of diabetic nephropathy in C57BL/6 mice. Diabetologia 54:1242-1251
32. Beisswenger PJ, Makita Z, Curphey TJ, Moore LL, Jean S, Brinck- Johnsen T, Bucala R, Vlassara H 1995 Formation of immunochemical advanced glycosylation end products precedes and correlates with early manifestations of renal and retinal disease in diabetes. Diabetes 44:824-829
33. Peppa M, Brem H, Cai W, Zhang JG, Basgen J, Li Z, Vlassara H, Uribarri J 2006 Prevention and reversal of diabetic nephropathy in db/db mice treated with alagebrium (ALT-711). Am J Nephrol 26:430-436 (Pubitemid 44971733)
34. Iacobini C, Menini S, Ricci C, Scipioni A, Sansoni V, Mazzitelli G, Cordone S, Pesce C, Pugliese F, Pricci F, Pugliese G 2009 Advanced lipoxidation end-products mediate lipid-induced glomerular injury: role of receptor-mediated mechanisms. J Pathol 218:360-369
35. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R 2000 Amelioration of accelerated diabetic mesangial expansion by treatment with a PKCβ inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14:439-447 (Pubitemid 30143162)
36. Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL 2006 Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase C≲βθλλ∀-null mice. Diabetes 55:3112-3120 (Pubitemid 44923650)
37. Geraldes P, King GL 2010 Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106:1319-1331
38. Ma J, Natarajan R, LaPage J, Lanting L, Kim N, Becerra D, Clemmons B, Nast CC, Surya Prakash GK, Mandal M, Adler SG 2005 12/15-Lipoxygenase inhibitors in diabetic nephropathy in the rat. Prostaglandins Leukot Essent Fatty Acids 72:13-20 (Pubitemid 39626783)
39. Yuan H, Lanting L, Xu ZG, Li SL, Swiderski P, Putta S, Jonnalagadda M, Kato M, Natarajan R 2008 Effects of cholesterol-tagged small interferingRNAstargeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes. Am J Physiol Renal Physiol 295:F605-F617
40. Szabó C, Biser A, Benko R, Böttinger E, Suszták K 2006 Poly(ADPribose) polymerase inhibitors ameliorate nephropathy of type 2 diabetic Leprdb/db mice. Diabetes 55:3004-3012 (Pubitemid 44923636)
41. Drel VR, Xu W, Zhang J, Pavlov IA, Shevalye H, Slusher B, Obrosova IG 2009 Poly(adenosine 5′-diphosphate-ribose) polymerase inhibition counteracts multiple manifestations of experimental type 1 diabetic nephropathy. Endocrinology 150:5273-5283
42. Flyvbjerg A, Dagnaes-Hansen F, De Vriese AS, Schrijvers BF, Tilton RG, Rasch R 2002 Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody. Diabetes 51:3090-3094
43. Ziyadeh FN 2008 Different roles for TGF-β and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes Res Clin Pract 82:S38-S41
44. Agardh CD, Stenram U, Torffvit O, Agardh E 2002 Effects of inhibition of glycation and oxidative stress on the development of diabetic nephropathy in rats. J Diabetes Complications 16:395-400 (Pubitemid 35449085)
45. DeRubertis FR, Craven PA, Melhem MF 2007 Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol. Metabolism 56:1256-1264 (Pubitemid 47223266)
46. Wu J, Zhang R, Torreggiani M, Ting A, Xiong H, Striker GE, Vlassara H, Zheng F 2010 Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation. Am J Pathol 176:2163-2176
47. Qi W, Mu J, Luo ZF, Zeng W, Guo YH, Pang Q, Ye ZL, Liu L, Yuan FH, Feng B 2011 Attenuation of diabetic nephropathy in diabetes rats induced by streptozotocin by regulating the endoplasmic reticulum stress inflammatory response. Metabolism 60:594-603
48. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, Abboud HE 2009 Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58:1201-1211
49. Kang SW, Natarajan R, Shahed A, Nast CC, LaPage J, Mundel P, Kashtan C, Adler SG 2003 Role of 12-lipoxygenase in the stimulation of p38 mitogen-activated protein kinase and collagen α5(IV) in experimental diabetic nephropathy and in glucose-stimulated podocytes. J Am Soc Nephrol 14:3178-3187 (Pubitemid 37509293)
50. Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE 2008 Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Nephrol Dial Transplant 23:1346-1354 (Pubitemid 351767511)
51. Drel VR, Pacher P, Stevens MJ, Obrosova IG 2006 Aldose reductase inhibition counteracts nitrosative stress and poly(ADP-ribose) polymerase activation in diabetic rat kidney and high-glucose-exposed human mesangial cells. Free Radic Biol Med 40:1454-1465
52. Eizirik DL, Cardozo AK, Cnop M 2008 The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 29:42-61 (Pubitemid 351252746)
53. Hotamisligil GS 2006 Inflammation and metabolic disorders. Nature 444:860-867 (Pubitemid 46024993)
54. Hotamisligil GS 2010 Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900-917
55. Ebenezer PJ, Mariappan N, Elks CM, Haque M, Francis J 2009 Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) 17:1994-2002
56. Weisberg SP, Leibel R, Tortoriello DV 2008 Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity. Endocrinology 149:3549-3558 (Pubitemid 351919581)
57. Shertzer HG, Schneider SN, Kendig EL, Clegg DJ, D'Alessio DA, Genter MB 2008 Acetaminophen normalizes glucose homeostasis in mouse models for diabetes. Biochem Pharmacol 75:1402-1410
58. Hoehn KL, Salmon AB, Hohnen-Behrens C, Turner N, Hoy AJ, Maghzal GJ, Stocker R, Van Remmen H, Kraegen EW, Cooney GJ, Richardson AR, James DE 2009 Insulin resistance is a cellular antioxidant defense mechanism. Proc Natl Acad Sci USA 106:17787-17792
59. Ikemura M, Nishikawa M, Hyoudou K, Kobayashi Y, Yamashita F, Hashida M 2010 Improvement of insulin resistance by removal of systemic hydrogen peroxide by PEGylated catalase in obese mice. Mol Pharm 7:2069-2076